Patents by Inventor Wallich Reinhard

Wallich Reinhard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Vaccine against Lyme disease
    Patent number: 6613331
    Abstract: The present invention provides a vaccine against Lyme disease, wherein it contains one or more monoclonal antibodies which are specific for the 31 kD antigen (OspA) or the 34 kD antigen (OspB) of Borrelia burgdorferi. The present invention also provides a process for obtaining this vaccine, as well as new monoclonal antibodies and antigens.
    Type: Grant
    Filed: October 7, 1999
    Date of Patent: September 2, 2003
    Assignees: Max-Planck-Gessellschaft zur förderung der Wissenschaften e.V., Deutsches Krebsforschun zentrum Stiftung des öffentlichen Rechts
    Inventors: Markus M. Simon, Ulrich E. Schaible, Klaus Eichmann, Michael Kramer, Wallich Reinhard
  • Hybridomas producing antibodies specific for lyme disease antigens OspA and OspB
    Patent number: 5856447
    Abstract: The present invention provides a vaccine against Lyme disease, wherein it contains one or more monoclonal antibodies which are specific for the 31 kD antigen (OspA) or the 34 kD antigen (OspB) of Borrelia burgdorferi.The present invention also provides a process for obtaining this vaccine, as well as new monoclonal antibodies, hybridomas and antigens.
    Type: Grant
    Filed: February 23, 1998
    Date of Patent: January 5, 1999
    Assignee: Max-Planck-Gesellschaft zur Forderung der Wissenschaften
    Inventors: Markus M. Simon, Ulrich E. Schaible, Klaus Eichmann, Michael Kramer, Wallich Reinhard
  • Passive vaccine against Lyme disease
    Patent number: 5780030
    Abstract: The present invention provides a vaccine against Lyme disease, wherein it contains one or more monoclonal antibodies which are specific for the 31 kD antigen (OspA) or the 34 kD antigen (OspB) of Borrelia burgdorferi. The present invention also provides a process for obtaining this vaccine, as well as new monoclonal anti-bodies and antigens.
    Type: Grant
    Filed: March 20, 1995
    Date of Patent: July 14, 1998
    Assignees: Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V., Deutsches Krebsforschun Zentrum Stiftung des Offentlichen Rechts
    Inventors: Markus M. Simon, Ulrich E. Schaible, Klaus Eichmann, Michael Kramer, Wallich Reinhard
  • Nucleic acid molecule encoding antigen associated with lyme disease
    Patent number: 5686267
    Abstract: A vaccine against Lyme disease, wherein it contains one or more monoclonal antibodies which are specific for the 31 kD antigen (OspA) or the 34 kD antigen (OspB) of Borrelia burgdorferi. The present invention also provides a process for obtaining this vaccine, as well as new monoclonal antibodies and antigens.
    Type: Grant
    Filed: March 20, 1995
    Date of Patent: November 11, 1997
    Assignees: Max-Planck-Gesellschaft zur Forderung der Wissenscaften E.V., Deutsches Krebsforschun Zentrum Stiftung des Offentlichen Rechts
    Inventors: Markus M. Simon, Ulrich E. Schaible, Klaus Eichmann, Michael Kramer, Wallich Reinhard
  • Borrelia burgdorferi strain 257
    Patent number: 5434077
    Abstract: The present invention provides a vaccine against Lyme disease, wherein it contains one or more monoclonal antibodies which are specific for the 31 kD antigen (OspA) or the 34 kD antigen (OspB) of Borrelia burgdorferi.The present invention also provides a process for obtaining this vaccine, as well as new monoclonal antibodies and antigens.
    Type: Grant
    Filed: May 27, 1993
    Date of Patent: July 18, 1995
    Assignees: Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V., Deutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts
    Inventors: Markus M. Simon, Ulrich E. Schaible, Klaus Eichmann, Michael Kramer, Wallich Reinhard
  • Vaccine against Lyme disease
    Patent number: 5178859
    Abstract: The present invention provides a vaccine against Lyme disease, wherein it contains one or more monoclonal antibodies which are specific for the 31 kD antigen (OspA) or the 34 kD antigen (OspB) of Borrelia burgdorferi.The present invention also provides a process for obtaining this vaccine, as well as new monoclonal antibodies and antigens.
    Type: Grant
    Filed: September 19, 1990
    Date of Patent: January 12, 1993
    Assignees: Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V., Deutsches Krebsforschungszentrum Stiftung des offentlichen Rechts
    Inventors: Markus M. Simon, Ulrich E. Schaible, Klaus Eichmann, Michael Kramer, Wallich Reinhard